摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N3-benzoyl-2'-deoxy-5-fluorouridine | 74233-80-0

中文名称
——
中文别名
——
英文名称
N3-benzoyl-2'-deoxy-5-fluorouridine
英文别名
3-Benzoyl-2'-deoxy-5-fluorouridine;3-benzoyl-5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
N<sup>3</sup>-benzoyl-2'-deoxy-5-fluorouridine化学式
CAS
74233-80-0
化学式
C16H15FN2O6
mdl
——
分子量
350.303
InChiKey
CPBKROZHSSOGKJ-YNEHKIRRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    543.1±60.0 °C(Predicted)
  • 密度:
    1.58±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    107
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    FUDZII, SEHTSUO;YAMASITA, DZYUNITI;TAKEHDA, SEHTSUO;TEHRADA, TADASI;YASUM+
    摘要:
    DOI:
  • 作为产物:
    描述:
    苯甲酰氯5-氟-2'-脱氧脲核苷三乙胺 作用下, 以 N,N-二甲基乙酰胺 为溶剂, 反应 12.0h, 以49%的产率得到N3-benzoyl-2'-deoxy-5-fluorouridine
    参考文献:
    名称:
    抗肿瘤药的研究。8.2′-脱氧-5-(三氟甲基)尿苷和2′-脱氧-5-氟尿苷的O-烷基衍生物的抗肿瘤活性。
    摘要:
    合成了2'-脱氧-5-(三氟甲基)尿苷(F3Thd)和2'-脱氧-5-氟尿苷(FUdR)的O-苄基和O-乙基衍生物。检查了化合物对小鼠肉瘤180的口服抗肿瘤活性。F3Thd的5'-O-乙基(3b),3'-O-乙基(3c),5'-O-苄基(3e)和3'-O-苄基(3f)衍生物的活性高4倍比F3Thd本身。在F3Thd的取代苄基衍生物中,3'-O-(对氯苄基)-F3Thd(3h)显示最高的活性,ED50不到F3Thd的十分之一。FUdR的5'-O-苄基(7c)和3'-O-苄基(7d)衍生物的活性与F3Thd的有效O-烷基衍生物的活性相等。
    DOI:
    10.1021/jm00121a025
点击查看最新优质反应信息

文献信息

  • 2'-deoxy-5-substituted uridine derivatives
    申请人:Taiho Pharmaceutical Company, Ltd.
    公开号:US05250673A1
    公开(公告)日:1993-10-05
    Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, ##STR1## wherein R.sub.1 is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R.sub.2 is a fluorine atom or a trifluoromethyl group; and any one of R.sub.3 and R.sub.4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents. The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.
    通式为##STR1##的新型2'-去氧-5-取代尿苷衍生物,其中R.sub.1是氢原子、苯甲酰基或四氢呋喃基;R.sub.2是氟原子或三氟甲基基团;R.sub.3和R.sub.4中的任意一个是氢原子,另一个是具有1至10个碳原子的烷基基团、具有2至6个碳原子的烯基基团、苄基基团,其取代基选择自卤原子、具有1至4个碳原子的烷基团、具有1至4个碳原子的烷氧基团和硝基,或具有1至3个碳原子的烷基团,其中一个或两个取代基是苯基。该新型2'-去氧-5-取代尿苷衍生物具有优异的抗肿瘤活性和较低的毒性,因此可用作抗肿瘤剂。
  • Novel 2'-deoxy-5-substituted uridine derivatives, processes for
    申请人:Taiho Pharmaceutical Company Limited
    公开号:US04886877A1
    公开(公告)日:1989-12-12
    Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, ##STR1## wherein R.sub.1 is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R.sub.2 is a fluorine atom or a trifluoromethyl group; and any one of R.sub.3 and R.sub.4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents. The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.
    一种新型的2'-脱氧-5-取代尿苷衍生物,其一般式为##STR1##其中,R.sub.1为氢原子、苯甲酰基或四氢呋喃基;R.sub.2为氟原子或三氟甲基基团;R.sub.3和R.sub.4中的任意一个为氢原子,另一个为具有1至10个碳原子的烷基、具有2至6个碳原子的烯基、苄基,其中苄基的取代基选自卤原子、具有1至4个碳原子的烷基、具有1至4个碳原子的烷氧基和硝基,或具有1至3个碳原子且具有一或两个苯基取代基的烷基。该新型的2'-脱氧-5-取代尿苷衍生物具有出色的抗肿瘤活性,毒性较小,因此可用作抗肿瘤剂。
  • Novel 2'-deoxy-5-substituted uridine derivatives, processes for preparing the same and antitumor agent containing the same
    申请人:TAIHO PHARMACEUTICAL COMPANY LIMITED
    公开号:EP0129984A1
    公开(公告)日:1985-01-02
    Novel 2'-deoxy-5-substituted uridine derivative represented by the general formula, wherein R, is a hydrogen atom, a benzoyl group or a tetrahydrofuranyl group; R2 is a fluorine atom or a trifluoromethyl group; and any one of R3 and R4 is a hydrogen atom and the other one is an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a benzyl group having as the substituents selected from the group consisting of a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms and a nitro group, or an alkyl group having 1 to 3 carbon atoms having one or two phenyl groups as the substituents. The novel 2'-deoxy-5-substituteduridine derivative possesses excellent antitumor activity with less toxicity, thus it is useful as antitumor agent.
    由通式代表的新型 2'-脱氧-5-取代尿苷衍生物、 其中 R 是氢原子、苯甲酰基或四氢呋喃基;R2 是氟原子或三氟甲基;R3和R4中的任何一个是氢原子,另一个是具有1至10个碳原子的烷基、具有2至6个碳原子的烯基、取代基选自以下组别的苄基:卤素原子、具有1至4个碳原子的烷基、具有1至4个碳原子的烷氧基和硝基,或具有1至3个碳原子的烷基,取代基为一个或两个苯基。 新型 2'-deoxy-5 取代尿苷衍生物具有极佳的抗肿瘤活性,毒性较低,因此可用作抗肿瘤药物。
  • 2'-Deoxy-5-fluorouridine derivatives
    申请人:TAIHO PHARMACEUTICAL CO., LTD.
    公开号:EP0331032A1
    公开(公告)日:1989-09-06
    2′-Deoxy-5-fluorouridine derivatives of the formula wherein, R¹ is hydrogen atom or an acyl group and R² and R³ are respectively hydrogen atom, an acyl group or a group of the formula wherein X¹ and X² are respectively oxygen atom or sulfur atom; R⁴ is a phenyl group, a benzyl group or a naphthyl group each of which may be substituted by an alkyl group, an alkoxyl group, an alkoxycarbonyl group, an alkyl­thio group, an acyl group, a halogen atom, trifluoromethyl group, nitro group, cyano group, carboxyl group and/or methy­lenedioxy group and R⁵ is an alkyl group, an alkenyl group or one of the groups represented by R⁴ which is the same as or different from R⁴, at least one of R² and R³ being a group of the formula which exhibit excellent antitumour activities and have lower toxicity, methods of the production thereof and antitumour compositions containing said 2′-deoxy-­5-fluorouridine derivatives.
    式中的 2′-脱氧-5-氟尿苷衍生物 其中,R¹为氢原子或酰基,R²和R³分别为氢原子、酰基或式中的基团 其中,X¹ 和 X² 分别为氧原子或硫原子;R⁴ 是苯基、苄基或萘基,每个苯基、苄基或萘基可被烷基、烷氧基、烷氧羰基、烷硫基、酰基、卤素原子、三氟甲基、硝基、氰基、羧基、卤素原子、三氟甲基、硝基、氰基、羧基取代、R⁵是烷基、烯基或与 R⁴ 相同或不同的 R⁴ 所代表的基团之一,R² 和 R³ 中至少有一个是式中的基团。 这些衍生物具有优异的抗肿瘤活性和较低的毒性,其生产方法以及含有所述 2′-脱氧-5-氟尿嘧啶衍生物的抗肿瘤组合物。
  • KODAMA, TSUTOMU;SEHNOURA, MASAAKI;AOYAMA, XADZIMEH;YAMAGUTI, TOMONOBU;KIT+
    作者:KODAMA, TSUTOMU、SEHNOURA, MASAAKI、AOYAMA, XADZIMEH、YAMAGUTI, TOMONOBU、KIT+
    DOI:——
    日期:——
查看更多